At World ADC London, innovation leads the way as 2026 spotlights breakthrough ADC advances, uniting global expertise to transform precision cancer treatment and elevate therapeutic impact across Europe.
World ADC London 2026 unites more than 800 senior European ADC leaders from biopharma, clinical practice, service providers, investment, and regulatory bodies to shape the next era of ADC development. This year’s programme focuses on securing ADCs as standard-of-care therapies by advancing novel payload mechanisms to overcome Topo1 resistance, improving translation of safe and effective ADCs into the clinic, and strengthening manufacturing capabilities. Join the community driving ADC innovation.
View Event
